Literature DB >> 16205720

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Alessandra Gaeta1, Robert C Hider.   

Abstract

The variety of factors and events involved in neurodegeneration renders the subject a major challenge. Neurodegenerative disorders include a number of different pathological conditions, which share similar critical metabolic processes, such as protein aggregation and oxidative stress, both of which are associated with the involvement of metal ions. In this review, Alzheimer's disease, Parkinson's disease and prion disease are discussed, with the aim of identifying common trends underlying these devastating neurological conditions. Chelation therapy could be a valuable therapeutic approach, since metals are considered to be a pharmacological target for the rationale design of new therapeutic agents directed towards the treatment of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205720      PMCID: PMC1751240          DOI: 10.1038/sj.bjp.0706416

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  160 in total

Review 1.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Protein folding and disease: a view from the first Horizon Symposium.

Authors:  Christopher M Dobson
Journal:  Nat Rev Drug Discov       Date:  2003-02       Impact factor: 84.694

Review 3.  A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

Authors:  Debomoy K Lahiri; Martin R Farlow; Kumar Sambamurti; Nigel H Greig; Ezio Giacobini; Lon S Schneider
Journal:  Curr Drug Targets       Date:  2003-02       Impact factor: 3.465

Review 4.  Progress towards a molecular-level structural understanding of amyloid fibrils.

Authors:  Robert Tycko
Journal:  Curr Opin Struct Biol       Date:  2004-02       Impact factor: 6.809

5.  Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

Authors:  Deepinder Kaur; Ferda Yantiri; Subramanian Rajagopalan; Jyothi Kumar; Jun Qin Mo; Rapee Boonplueang; Veena Viswanath; Russell Jacobs; Lichuan Yang; M Flint Beal; Dino DiMonte; Irene Volitaskis; Lisa Ellerby; Robert A Cherny; Ashley I Bush; Julie K Andersen
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

Review 6.  Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease.

Authors:  Fernanda G De Felice; Sérgio T Ferreira
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

Review 7.  Neurodegenerative disorders of protein aggregation.

Authors:  Barkur S Shastry
Journal:  Neurochem Int       Date:  2003-07       Impact factor: 3.921

8.  A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease.

Authors:  Ryong-Woon Shin; Theo P A Kruck; Harunobu Murayama; Tetsuyuki Kitamoto
Journal:  Brain Res       Date:  2003-01-24       Impact factor: 3.252

Review 9.  Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.

Authors:  Kelly A Conway; Ellen W Baxter; Kevin M Felsenstein; Allen B Reitz
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease.

Authors:  Henrik Wilms; Philip Rosenstiel; Jobst Sievers; Günther Deuschl; Luigi Zecca; Ralph Lucius
Journal:  FASEB J       Date:  2003-01-21       Impact factor: 5.191

View more
  79 in total

1.  Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state.

Authors:  Tobias Högen; Johannes Levin; Felix Schmidt; Mario Caruana; Neville Vassallo; Hans Kretzschmar; Kai Bötzel; Frits Kamp; Armin Giese
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

Review 2.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

3.  Early post-natal iron administration induces astroglial response in the brain of adult and aged rats.

Authors:  Liana Lisboa Fernandez; Maria Noêmia Martins de Lima; Felipe Scalco; Gustavo Vedana; Clívia Miwa; Arlete Hilbig; Mônica Vianna; Nadja Schröder
Journal:  Neurotox Res       Date:  2010-12-17       Impact factor: 3.911

Review 4.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

5.  Rapid and Label-Free Strategy to Isolate Aptamers for Metal Ions.

Authors:  Hao Qu; Andrew T Csordas; Jinpeng Wang; Seung Soo Oh; Michael S Eisenstein; Hyongsok Tom Soh
Journal:  ACS Nano       Date:  2016-07-11       Impact factor: 15.881

6.  Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.

Authors:  Jun Peng; May Lin Oo; Julie K Andersen
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

Review 7.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

Review 8.  A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.

Authors:  Kari A Trumbull; Joseph S Beckman
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 9.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

10.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.

Authors:  Yong Peng; Chengshan Wang; Howard H Xu; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2009-11-18       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.